AstraZeneca Pharma India Authorizes Key Managerial Personnel for Materiality Disclosures
AstraZeneca Pharma India Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 11:40 pm
AstraZeneca Pharma India Authorizes Key Managerial Personnel for Materiality Disclosures AstraZeneca Pharma India Limited has updated its authorized Key Managerial Personnel under Regulation 30(5) of SEBI LODR Regulations, 2015, effective 9th Nov'26, for determining event materiality and stock exchange disclosures. The designated officials comprise Managing Director Praveen Rao Akkinepally, Chief Financial Officer Atul Tandon, and Company Secretary Tanya Sanish.
Original exchange filing (PDF)
More announcements from AstraZeneca Pharma India Ltd
- Please find the enclosed document of the Company as per the captioned subject. This is being resubmitted as the weblink was not correctly re-directing to the relevant web page in the earlier .... 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 07 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about General Updates 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about Appointment/ Change in designation of Senior Management Personnel 路 05 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 05 Nov 2026
